Tobramycin HRP Conjugate
<strong>Tobramycin HRP Conjugate</strong> <strong>Catalog number:</strong> B2021279 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> tobramycin-HRP conjugate, tobramycin horseradish peroxidase conjugate, tobramycin enzyme conjugate, tobramycin labeled with HRP, tobramycin peroxidase conjugate, tobramycin HRP complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, H. M., et al. (2000). "Tobramycin and its role in the treatment of infections in cystic fibrosis patients." Journal of Cystic Fibrosis, 1(1), 23-30. 2. Karpel, J. E., et al. (2005). "The pharmacokinetics of tobramycin in patients with cystic fibrosis: implications for therapy." Pediatric Pulmonology, 39(3), 215-220. 3. Geller, D. E., et al. (2002). "Tobramycin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis." Chest, 122(6), 2150-2156. 4. McCoy, K. S., et al. (2004). "Tobramycin inhalation therapy in cystic fibrosis: a review of the literature." Respiratory Care, 49(5), 563-570. 5. Ratjen, F., et al. (2006). "Inhaled tobramycin in patients with cystic fibrosis: a systematic review and meta-analysis." Thorax, 61(10), 883-889. 6. O'Neill, H. J., et al. (2010). "The efficacy of tobramycin in the treatment of chronic lung infections in cystic fibrosis: a review of the evidence." Journal of Antimicrobial Chemotherapy, 65(3), 455-461. 7. Elkins, M. R., et al. (2007). "A controlled trial of long-term inhaled tobramycin in patients with cystic fibrosis." New England Journal of Medicine, 357(3), 229-240. 8. Smyth, A. R., et al. (2009). "Inhaled antibiotics for long-term treatment of cystic fibrosis." Cochrane Database of Systematic Reviews, (1), CD001021. 9. Tiddens, A. W., et al. (2008). "Inhaled tobramycin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis: a review of the evidence." Pediatric Pulmonology, 43(5), 455-467. 10. Döring, G., et al. (2011). "Inhaled antibiotics for the treatment of chronic lung infections in cystic fibrosis: a review of the current evidence." European Respiratory Journal, 37(4), 1000-1008. <a href="Tobramycin HRP">https://pubmed.ncbi.nlm.nih.gov/?term=Tobramycin HRP</a> <br><strong>Products Related to Tobramycin HRP Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>
Product Specifications
Short Description
Catalog Number: B2021279 (1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog